USB402162I5 - - Google Patents
Info
- Publication number
- USB402162I5 USB402162I5 US40216273A USB402162I5 US B402162 I5 USB402162 I5 US B402162I5 US 40216273 A US40216273 A US 40216273A US B402162 I5 USB402162 I5 US B402162I5
- Authority
- US
- United States
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/402,162 US3994902A (en) | 1971-06-23 | 1973-10-01 | Certain 1,2-diphenyl-1,2,3,4-tetrahydroquinoline compounds |
| US05/593,166 US4049715A (en) | 1973-10-01 | 1975-07-03 | 3-[2-(4-Anisidino)phenyl]-1-phenyl-1-propiophenones and propanols |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00156070A US3819637A (en) | 1971-06-23 | 1971-06-23 | 1,2-diphenyl-1,2,3,4-tetrahydroquinolines |
| US05/402,162 US3994902A (en) | 1971-06-23 | 1973-10-01 | Certain 1,2-diphenyl-1,2,3,4-tetrahydroquinoline compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US00156070A Division US3819637A (en) | 1971-06-23 | 1971-06-23 | 1,2-diphenyl-1,2,3,4-tetrahydroquinolines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US05/593,166 Continuation-In-Part US4049715A (en) | 1973-10-01 | 1975-07-03 | 3-[2-(4-Anisidino)phenyl]-1-phenyl-1-propiophenones and propanols |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| USB402162I5 true USB402162I5 (en) | 1976-03-02 |
| US3994902A US3994902A (en) | 1976-11-30 |
Family
ID=26852843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US05/402,162 Expired - Lifetime US3994902A (en) | 1971-06-23 | 1973-10-01 | Certain 1,2-diphenyl-1,2,3,4-tetrahydroquinoline compounds |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3994902A (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4058532A (en) * | 1975-07-03 | 1977-11-15 | Sterling Drug Inc. | 1-Phenyl-3,4-dihydrocarbostyrils |
| US4652681A (en) * | 1982-04-15 | 1987-03-24 | Drug Science Foundation | Aminoalkoxy derivatives of propranolol for immunoassay applications |
| US6825214B2 (en) | 2000-08-14 | 2004-11-30 | Teva Pharmaceutical Industries, Ltd. | Substantially pure cilostazol and processes for making same |
| US6515128B2 (en) | 2000-03-20 | 2003-02-04 | Teva Pharmaceutical Industries Ltd. | Processes for preparing cilostazol |
| US6525201B2 (en) | 2000-03-20 | 2003-02-25 | Teva Pharmaceutical Industries, Ltd. | Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)-3-chloropropionamide |
| JP2004531559A (en) * | 2001-05-22 | 2004-10-14 | イーライ・リリー・アンド・カンパニー | Tetrahydroquinoline derivatives for inhibiting diseases associated with estrogen deficiency or abnormal physiological response to endogenous estrogen |
| US7056931B2 (en) * | 2001-05-22 | 2006-06-06 | Eli Lilly And Company | 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| CN109796352B (en) * | 2019-03-28 | 2022-02-15 | 广东工业大学 | Ortho-alkylated arylamine and preparation method thereof |
-
1973
- 1973-10-01 US US05/402,162 patent/US3994902A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US3994902A (en) | 1976-11-30 |